Title
Thyroid Stimulating Hormone and Thyroid Hormones (Triiodothyronine and Thyroxine)
Authoring Organization
Publication Month/Year
August 31, 2023
Last Updated Month/Year
October 11, 2024
Document Type
Other
Country of Publication
US
Document Objectives
This document aims to provide a state-of-the-art status report on the progress achieved in thyroid testing, including thyrotropin (TSH), thyroxine (T4), and triiodothyronine (T3).
Target Patient Population
Patients with diagnosed or suspected thyroid disorders
Target Provider Population
General practitioners, endocrinologists, and laboratory professionals.
Inclusion Criteria
Male, Female, Adult, Older adult
Health Care Settings
Ambulatory, Correctional facility, Hospital, Laboratory services, Long term care, Outpatient
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Diagnosis, Assessment and screening
Diseases/Conditions (MeSH)
D007037 - Hypothyroidism, D006111 - Graves Disease, D006980 - Hyperthyroidism
Keywords
thyroid stimulating hormone (TSH), triiodothyronine (T3), thyroxine (T4), thyrotropin, TSH, thyroxine, T4, triiodothyronine, T3, thyroid function
Source Citation
Van Uytfanghe K, Ehrenkranz J, Halsall D, et al. Thyroid Stimulating Hormone and Thyroid Hormones (Triiodothyronine and Thyroxine): An American Thyroid Association-Commissioned Review of Current Clinical and Laboratory Status. Thyroid. 2023;33(9): 1013-1028. doi:10.1089/thy.2023.0169